Compare VGM & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VGM | PRME |
|---|---|---|
| Founded | N/A | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.9M | 666.1M |
| IPO Year | 1994 | 2022 |
| Metric | VGM | PRME |
|---|---|---|
| Price | $10.53 | $3.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 173.8K | ★ 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.31 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,983,000.00 |
| Revenue This Year | N/A | $95.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.28 | $1.11 |
| 52 Week High | $10.66 | $6.94 |
| Indicator | VGM | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 48.68 |
| Support Level | $10.00 | $3.19 |
| Resistance Level | $10.66 | $4.04 |
| Average True Range (ATR) | 0.07 | 0.23 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 71.43 | 58.39 |
Invesco Trust for Investment Grade Municipals is active in the financial services sector. Its investment objective is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.